354 related articles for article (PubMed ID: 36389768)
1. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis.
Zhou G; Zhang N; Meng K; Pan F
Front Immunol; 2022; 13():1001623. PubMed ID: 36389768
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota shed new light on the management of immune-related adverse events.
Tan B; Liu YX; Tang H; Chen D; Xu Y; Chen MJ; Li Y; Wang MZ; Qian JM
Thorac Cancer; 2022 Oct; 13(19):2681-2691. PubMed ID: 36043345
[TBL] [Abstract][Full Text] [Related]
3. Refractory Immune Checkpoint Inhibitor-induced Colitis Improved by Fecal Microbiota Transplantation: A Case Report.
Dai C; Liu WX
Inflamm Bowel Dis; 2022 Mar; 28(3):e43-e44. PubMed ID: 34751747
[No Abstract] [Full Text] [Related]
4. The multifaceted roles of common gut microbiota in immune checkpoint inhibitor-mediated colitis: From mechanism to clinical application.
Han X; Zang D; Liu D; Chen J
Front Immunol; 2022; 13():988849. PubMed ID: 36189293
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer.
Chang AE; Golob JL; Schmidt TM; Peltier DC; Lao CD; Tewari M
Trends Cancer; 2021 Jul; 7(7):583-593. PubMed ID: 33741313
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Wang Y; Wiesnoski DH; Helmink BA; Gopalakrishnan V; Choi K; DuPont HL; Jiang ZD; Abu-Sbeih H; Sanchez CA; Chang CC; Parra ER; Francisco-Cruz A; Raju GS; Stroehlein JR; Campbell MT; Gao J; Subudhi SK; Maru DM; Blando JM; Lazar AJ; Allison JP; Sharma P; Tetzlaff MT; Wargo JA; Jenq RR
Nat Med; 2018 Dec; 24(12):1804-1808. PubMed ID: 30420754
[TBL] [Abstract][Full Text] [Related]
7. Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis.
Halsey TM; Thomas AS; Hayase T; Ma W; Abu-Sbeih H; Sun B; Parra ER; Jiang ZD; DuPont HL; Sanchez C; El-Himri R; Brown A; Flores I; McDaniel L; Ortega Turrubiates M; Hensel M; Pham D; Watowich SS; Hayase E; Chang CC; Jenq RR; Wang Y
Sci Transl Med; 2023 Jun; 15(700):eabq4006. PubMed ID: 37315113
[TBL] [Abstract][Full Text] [Related]
8. Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review.
Pierrard J; Seront E
Curr Oncol; 2019 Dec; 26(6):395-403. PubMed ID: 31896938
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Immune Checkpoint Inhibitors-Based Immunotherapy.
Tian M; Zhang S; Tseng Y; Shen X; Dong L; Xue R
Anticancer Agents Med Chem; 2022; 22(7):1244-1256. PubMed ID: 34229597
[TBL] [Abstract][Full Text] [Related]
11. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach.
Del Gaudio A; Di Vincenzo F; Petito V; Giustiniani MC; Gasbarrini A; Scaldaferri F; Lopetuso LR
Inflamm Bowel Dis; 2024 Jun; 30(6):1018-1031. PubMed ID: 37801695
[TBL] [Abstract][Full Text] [Related]
12. Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma.
Zhang H; Hong Y; Wu T; Ben E; Li S; Hu L; Xie T
Front Immunol; 2024; 15():1401967. PubMed ID: 38915399
[TBL] [Abstract][Full Text] [Related]
13. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer.
Kang YB; Cai Y
World J Gastroenterol; 2021 Aug; 27(32):5362-5375. PubMed ID: 34539138
[TBL] [Abstract][Full Text] [Related]
14. The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients.
Natarelli N; Aflatooni S; Boby A; Krenitsky A; Grichnik J
J Drugs Dermatol; 2024 Feb; 23(2):78-84. PubMed ID: 38306142
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
Nakane T; Mitsuyama K; Yamauchi R; Kakuma T; Torimura T
Kurume Med J; 2023 Jul; 68(2):43-52. PubMed ID: 37100606
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management.
Tang L; Wang J; Lin N; Zhou Y; He W; Liu J; Ma X
Front Immunol; 2021; 12():800879. PubMed ID: 34992611
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome in modulating immune checkpoint inhibitors.
Li X; Zhang S; Guo G; Han J; Yu J
EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation for Immune Checkpoint Inhibitor-Induced Colitis Is Safe and Contributes to Recovery: Two Case Reports.
Groenewegen B; Terveer EM; Joosse A; Barnhoorn MC; Zwittink RD
J Immunother; 2023 Jul-Aug 01; 46(6):216-220. PubMed ID: 37216289
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicity.
Shatila M; Ma W; Cui Y; Naz S; S Thomas A; N De Toni E; Török HP; Khaled NB; Altan M; Schneider B; Wang Y
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7793-7803. PubMed ID: 37029815
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
Westdorp H; Sweep MWD; Gorris MAJ; Hoentjen F; Boers-Sonderen MJ; van der Post RS; van den Heuvel MM; Piet B; Boleij A; Bloemendal HJ; de Vries IJM
Front Immunol; 2021; 12():768957. PubMed ID: 34777387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]